Bombay HC restores Park Inn Navi Mumbai’s food licence after FDA suspension

The Bombay High Court quashed Maharashtra FDA’s suspension of Park Inn by Radisson Navi Mumbai’s FSSAI licence, calling the action disproportionate given a reported 95% hygiene-compliance score and two insects found during inspection. The FDA must submit a wider inspection status report by July 31.

— Source publishedThu, 30 Jul, 2026, 12:12 IST·First seen Thu, 30 Jul, 2026, 12:23 IST·Source ET Small Business

What happened

Bombay High Court quashed Maharashtra FDA’s suspension of Park Inn by Radisson Navi Mumbai’s FSSAI licence, citing its 95% hygiene compliance and

Key facts

  • four-star
  • two insects
  • 95% compliance score
  • July 3
  • July 31

Why this matters

Acquirers and partners in foodservice should diligence licence histories, inspection records and crisis-response processes, with particular attention to whether compliance systems can substantiate proportional enforcement appeals.

What to watch

  • Contents of the FDA's July 31 inspection status report, especially violation rates at government and semi-government establishments.
  • Whether the FDA appeals the ruling or issues revised suspension and inspection guidance.
  • Any repeat inspection, adverse food sample, customer illness allegation or fresh pest-control violation at Park Inn Navi Mumbai.
  • Number of licence suspensions versus warning notices issued by Maharashtra FDA in the following quarters.
  • Whether other high courts cite the ruling in challenges to FSSAI or state food-safety enforcement actions.
  • Maharashtra FDA is likely to prepare a wider compliance-status report covering government and semi-government food establishments before the July 31 deadline.
  • Park Inn by Radisson Navi Mumbai will likely maintain enhanced hygiene documentation, pest-control logs and third-party audit evidence to prevent renewed regulatory action.
  • Organized hospitality chains may review FSSAI incident-response protocols and legal escalation playbooks for suspension notices.
  • FDA may issue corrective-action notices and shorter conditional compliance windows more often before pursuing licence suspension in non-severe cases.